Literature DB >> 4082067

Ultrastructural analysis of malformations of the embryonic neural axis induced by in vitro hyperglycemic conditions.

E A Reece, E Pinter, C Z Leranth, M Garcia-Segura, M K Sanyal, J C Hobbins, M J Mahoney, F Naftolin.   

Abstract

Neural tube defects are the most common malformations associated with diabetic pregnancies. Although the teratogenic effects of excess glucose have been investigated in in vivo and in vivo studies, a cellular basis for neural tube defects has not been elucidated. We used rat embryo culture to study the organogenesis period of development, with excess d-glucose added to the serum medium to induce neural tube anomalies. Light and electron microscopic examination of control 12-day-old embryos grown 48 hours in culture revealed blastlike cells with few organelles or cellular processes. Twelve-day-old embryos cultured in excess d-glucose had advanced cellular maturation with differentiation, including the presence of free polysomes and copious cell processes, regardless of whether they had an open neural tube. Cytoarchitectural changes such as decreased numbers of mitotic figures with mitotic cells in the mantle layer were focally distributed throughout the neural epithelium but with predominance at the site of failed closure. In vivo studies failed to demonstrate neural processes in day 12 normal embryos. Fourteen-day-old embryos grown in utero also had foci of cell processes in the neural tube but to a much lesser degree than that observed in the in vitro day 12 glucose-exposed embryos. The cellular aberrations in the excess d-glucose-treated embryos are characteristic of a premature maturational change. Since they are present in excess d-glucose-exposed embryos with or without failure of neural tube closure, these maturational and cytoarchitectural changes may contribute to the cellular basis for neural tube defects.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4082067     DOI: 10.1002/tera.1420320306

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  8 in total

Review 1.  Modeling anterior development in mice: diet as modulator of risk for neural tube defects.

Authors:  Claudia Kappen
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-10-04       Impact factor: 3.908

2.  SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy.

Authors:  Hongbo Weng; Xuezheng Li; E Albert Reece; Peixin Yang
Journal:  Am J Obstet Gynecol       Date:  2012-02-22       Impact factor: 8.661

Review 3.  Some of the experimental and clinical aspects of the effects of the maternal diabetes on developing hippocampus.

Authors:  Javad Hami; Fatemeh Shojae; Saeed Vafaee-Nezhad; Nasim Lotfi; Hamed Kheradmand; Hossein Haghir
Journal:  World J Diabetes       Date:  2015-04-15

Review 4.  Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling.

Authors:  Peixin Yang; E Albert Reece; Fang Wang; Rinat Gabbay-Benziv
Journal:  Am J Obstet Gynecol       Date:  2014-11-27       Impact factor: 8.661

Review 5.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

6.  The Nrf2 Activator Vinylsulfone Reduces High Glucose-Induced Neural Tube Defects by Suppressing Cellular Stress and Apoptosis.

Authors:  Daoyin Dong; E Albert Reece; Peixin Yang
Journal:  Reprod Sci       Date:  2016-01-21       Impact factor: 3.060

Review 7.  Diabetes and apoptosis: neural crest cells and neural tube.

Authors:  James H Chappell; Xiao Dan Wang; Mary R Loeken
Journal:  Apoptosis       Date:  2009-12       Impact factor: 4.677

8.  c-Jun NH2-terminal kinase 1/2 and endoplasmic reticulum stress as interdependent and reciprocal causation in diabetic embryopathy.

Authors:  Xuezheng Li; Cheng Xu; Peixin Yang
Journal:  Diabetes       Date:  2012-09-06       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.